Unisync announces the retirement of Douglas F. Good as CEO

Unisync announces the retirement of Douglas F. Good as CEO GlobeNewswire July 07, 2025 TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”) (TSX: UNI) (OTC: USYNF) today announced that Douglas F. Good, the Company's Chief Executive Officer, will retire as CEO and a director effective July 15, 2025. Chairman Tim Gu will assume […]

Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025

Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025 GlobeNewswire July 07, 2025 NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Yiviva, a clinical-stage biotechnology company pioneering systems biology-driven therapeutics, announced data from its multi-regional, randomized, double-blind, placebo-controlled Phase 2b study of sorafenib

Almaden Provides Update on Arbitration Procedure with Mexico

Almaden Provides Update on Arbitration Procedure with Mexico GlobeNewswire July 07, 2025 VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) announces that a public copy of the Memorial document (“Memorial”) that it filed in March of this year regarding its international arbitration proceedings

Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro(TM) (repotrectinib)

Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro(TM) (repotrectinib) GlobeNewswire July 07, 2025 LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent specialty pharmacy, has added Augtyro(TM) (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro was initially approved on November 15,

Brixton Metals Announces Flow-Through Private Placement of $2.3 Million

Brixton Metals Announces Flow-Through Private Placement of $2.3 Million GlobeNewswire July 07, 2025 Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton“) is pleased to announce a non-brokered private

FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership

FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership GlobeNewswire July 07, 2025 DANBURY, Conn., July 07, 2025 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) President and CEO Jason Few has issued a statement praising the “One Big Beautiful Bill Act” (OBBBA) for its direct

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States GlobeNewswire July 07, 2025 CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company“) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment

CryptoMiningFirm 2025 Trusted Free Bitcoin Cloud Mining Platform Launches New Mobile App

CryptoMiningFirm 2025 Trusted Free Bitcoin Cloud Mining Platform Launches New Mobile App CRYPTO MINING FIRM gives you a worry-free, secure, and eco-friendly cloud mining experience, allowing customers all over the world to invest in daily cryptocurrency earnings. Combining the most advanced cloud protocols with military-grade security standards, your funds are protected — while mining Bitcoin,

Class Action Alert: Levi & Korsinsky Reminds Krispy Kreme (DNUT) Investors of July 15, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / July 7, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=155716&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

July 21, 2025 Deadline: Join Class Action Lawsuit Against DoubleVerify Holdings, Inc. (DV) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / July 7, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=155715&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top